Akso Health (AHG) Long-Term Deferred Tax (2017 - 2026)
Akso Health's (AHG) quarterly Long-Term Deferred Tax came in at $4.9 million in Q1 2026, down 88.23% YoY from $41.3 million in Q1 2025, and down 88.23% on a QoQ basis from $41.3 million in Q1 2025.
Akso Health (AHG) Long-Term Deferred Tax (2017 - 2026) Analysis & Trends
Akso Health (AHG) has 6 years of Long-Term Deferred Tax data on file, last reported at $4.9 million in Q1 2026.
- Quarterly Long-Term Deferred Tax fell 88.23% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (down 88.23% YoY) and the FY2026 annual result came in at $4.9 million, down 88.23% from the prior year.
- Long-Term Deferred Tax declined to $4.9 million in Q1 2026, from $41.3 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $41.3 million in Q1 2025 to a low of $4.9 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.86 Mn |
| Mar 31, 2025 | 41.27 Mn |
| Mar 31, 2020 | 7.47 Mn |
| Sep 30, 2019 | 2.74 Mn |
| Mar 31, 2019 | 4.00 Mn |
| Dec 31, 2018 | 2.38 Mn |
| Mar 31, 2017 | 400,062.00 |